TCF7L2 and metabolic syndrome: In other studies, GWAS associations have shown that transcription factor 7-like 2 (TCF7L2), which is part of the Wnt signaling pathway, mediates metabolic syndrome trait susceptibility towards developing diabetes and dyslipidemia [92].